Arovella Therapeutics (ASX:ALA) - Key People
ASX:ALA · Directors, executives and key personnel · 12 month lookback
Mentioned in
Arovella secures $4.03 million refund as ALA-101 trial approaches first dosing
22 Oct 2026
Healthcare Wrap - Week 41 (5 Oct -> 9 Oct) 2026
10 Oct 2026
Arovella’s second ALA-101 batch clears the way for Phase 1 expansion
7 Oct 2026
Market Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Mentioned in
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Arovella Advances CAR-iNKT Trials with $14.4 Million Cash Backing
27 July 2026
Healthcare Wrap - Week 19 (4 May -> 8 May) 2026
9 May 2026
Arovella Appoints Nicole Van Der Weerden as Acting CEO Ahead of Key Trial
7 May 2026
Also Mentioned
People named in Arovella Therapeutics (ASX:ALA) articles over the last 12 months, by frequency.
David Williams
· 11 articles
Andrew Nash
· 8 articles
Debora Barton
· 6 articles
Mike Perry
· 4 articles
Michael Thurn
· 4 articles
Mark Diamond
· 4 articles
Professor Gianpietro Dotti
· 3 articles
Elizabeth Stoner
· 3 articles
Professor Cameron Turtle
· 2 articles
Salvatore Fiorenza
· 2 articles
Gary Phillips
· 2 articles
Tim Lusco
· 2 articles
Lachlan Mallia
· 2 articles
B G McVeigh
· 2 articles
Thomas Duthy
· 1 article